Ozempic has gotten most of the name recognition associated with weight-loss drugs, it's not the only drug in this category ...

Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, but I see one as the clear-cut winner for ...

While Novo Nordisk's (NYSE: NVO) Ozempic has gotten most of the name recognition associated with weight-loss drugs, it's not the only drug in this category doing well. While Elon Musk recently ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Eli Lilly wasn’t one of them. The 10 stocks that made the cut ...

Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology ...

Fast-growing drugmaker Eli ... s level one and that we found here. This environment will support all of that, which is fantastic. Second is workforce, and we’re impressed with the team we ...

LONDON, Dec 5 (Reuters) - Britain's drugs cost-effectiveness watchdog NICE said on Thursday it will recommend Eli Lilly's (LLY.N ... for people with at least one weight-related condition ...

From PBMs to abortion, there are plenty of health policy issues that will vie for the spotlight in 2025. For pharma marketers ...